Leadership Page ProQR's leadership is a strong team with proven track record. Find out who is on our management team, supervisory board and scientific advisory board.
Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes Presentation Axiomer® platform applicability and potential in therapeutically relevant models for targeted RNA editing presented at TIDES EU 2018 by Antti Aalto - ProQR Therapeutics November 06, 2018